When was Diaceutics founded?

Diaceutics was founded in 2005 and raised its 1st funding round 13 years after it was founded.

Where is Diaceutics located?

Diaceutics is headquartered in Belfast, United Kingdom.

How many employees does Diaceutics have?

As of Jul 31, 2026, the latest employee count at Diaceutics is 206.

Is Diaceutics a funded company?

Diaceutics is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Venture Debt round, raised on Apr 05, 2018.

When was the latest funding round of Diaceutics?

Diaceutics' latest funding was a $***** Post IPO round on Jun 11, 2020, with participation from 0 investor. Its primary sector is Biopharma Outsourcing. In United Kingdom, the Biopharma Outsourcing sector has seen $20.7M in funding in 2026 to date.

Where does Diaceutics rank among its competitors?

Diaceutics ranks 7th amongst 1416 active competitors, of which 27 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of Diaceutics?

Diaceutics' top competitors include Clinigen, CMIC HOLDINGS and IntegriChain. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

Diaceutics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Diaceutics Group acts as an integrator in the precision medicine space. The company uses analytics, software, services and consulting to enable integration of therapies and diagnostics into the treatment pathway. The company's services include strategic consulting; digital decision tools and training; laboratory test commercialization; and branding and communication of personalized medicine solutions. The Group’s divisions include: Labceutics, Diaceutics AIS, Lceltics, and Bioceutics. It client list includes Novartis, Pfizer, Boehringer Ingelheim, MedImmune, AstraZeneca and Bristol Myers-Squibb, the Bill & Melinda Gates Foundation and many more.

Website: www.diaceutics.com/
Social

Key Metrics

Founded Year

2005

Location

Belfast, United Kingdom

Stage

Public

Latest Funding Round

Post IPO, Jun 11, 2020, $*****

Investors

Herald Investment Management & 5 more

Ranked

7^th among 1416 active competitors

Employee Count

206 as on Jul 31, 2026

Similar Companies

Clinigen & 1675 more

Exit Details

Public

View Diaceutics' full profile

Diaceutics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Diaceutics PLC CIN: - , Germany, Active		-	133 (As on Dec 31, 2021)

Diaceutics got listed on Mar 21, 2019.

Click here to take a look at Diaceutics's IPO in detail

Diaceutics has raised funding over 2 rounds. Its first funding round was on Apr 05, 2018. Diaceutics has 6 institutional investors.

Here is the list of recent funding rounds of Diaceutics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 11, 2020	7132212	Post IPO	5042119	3180138	4721151	7885927
Apr 05, 2018	8972913	Venture Debt	9577020	5058925	3444069	SVB & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Diaceutics's funding rounds and investors

Diaceutics' employee count trend

Diaceutics has 206 employees as of Jul 26. Here is Diaceutics's employee count trend over the years:

Uncover Diaceutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Diaceutics include Clinigen, CMIC HOLDINGS and IntegriChain. Here is the list of Top 10 competitors of Diaceutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
2nd	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
3rd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	58/100
4th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	57/100
5th	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Baird Capital, Intertrust & 8 others	56/100
6th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
7th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
8th	Science Group 1986, Cambridge (United Kingdom), Public	Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors	-	Herald Investment Management	49/100
9th	Sequence 2002, Morrisville (United States), Acquired	Consulting services provider	-	-	49/100
10th	Oxford PharmaGenesis 1998, Oxford (United Kingdom), Acquired	Provider of medical affairs, marketing, communication, consultancy, and other services for healthcare sector	-	-	48/100